<?xml version="1.0" encoding="UTF-8"?>
<p>Our cohort included 2300 HIV positive patients followed in three different infectious diseases units of one Marseille University Hospital. The incidence of HAV infection in our cohort of HIV infected patients was assessed between 1 January 2017 and 31 December 2017. We tested for HAV all symptomatic patients and a positive case was confirmed on the basis of concurrent detection in serum of anti-HAV IgM by an immunoenzymatic assay (Architect Abott assays, Abbott Diagnostics, Mannheim, Germany) and HAV RNA by an 
 <italic>in-house</italic> PCR assay [
 <xref rid="ref2" ref-type="bibr">2</xref>].
</p>
